Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aequus Pharmaceuticals Inc (AQSZF)

Aequus Pharmaceuticals Inc (AQSZF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AQSZF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0942 unch
on 09/15/21
0.1223 -22.98%
on 08/24/21
-0.0155 (-14.13%)
since 08/13/21
3-Month
0.0764 +23.30%
on 06/18/21
0.1223 -22.98%
on 08/24/21
-0.0084 (-8.19%)
since 06/15/21
52-Week
0.0660 +42.73%
on 11/20/20
0.2300 -59.04%
on 03/03/21
+0.0045 (+5.02%)
since 09/15/20

Most Recent Stories

More News
Aequus Reports Second Quarter 2021 Financial Highlights

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertise

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus") a speciality pharmaceutical company, is pleased to announce that Dr. Robert K. Koenekoop MD, MSc, PhD, FRCS(C), FARVO has joined as a medical...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus and reVision to Collaborate on Stargardt Disease Program

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus") and reVision Therapeutics, Inc. ("reVision") announce a collaboration on the development of a therapy for Stargardt disease. Aequus is...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides Commercial Update

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Proactive news headlines including Aequus Pharmaceuticals, Organic Garage, Xigem Technologies and WeedMD

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

AQSZF : 0.0942 (-11.13%)
OG.VN : 0.290 (+1.75%)
Aequus Provides General Update and First Quarter 2021 Financial Highlights

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides General Update and Reports Record 2020 Financial Results

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference

Aequus Pharmaceuticals Inc. (TSX: AQS, OTCQB: AQSZF), a Canadian based specialty pharmaceutical company, will be presenting at the 2021 Bloom Burton & Co. Healthcare Investor Conference. Chairman and CEO,...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides update on Warrant Acceleration

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Announces Notice of Warrant Acceleration

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.0942
2nd Resistance Point 0.0942
1st Resistance Point 0.0942
Last Price 0.0942
1st Support Level 0.0942
2nd Support Level 0.0942
3rd Support Level 0.0942

See More

52-Week High 0.2300
Fibonacci 61.8% 0.1674
Fibonacci 50% 0.1480
Fibonacci 38.2% 0.1286
Last Price 0.0942
52-Week Low 0.0660

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar